<DOC>
	<DOCNO>NCT03090568</DOCNO>
	<brief_summary>The purpose study compare bioavailability tolerability BIA 5-453 fast fed condition .</brief_summary>
	<brief_title>Bioavailability Study BIA 5-453</brief_title>
	<detailed_description>This Single-centre , two-way crossover , randomise , open-label study 12 healthy male volunteer . Subjects receive single oral 200 mg dose BIA 5-453 follow standard meal one period , follow least 10 hour fast another period . Treatment period separate washout interval 2 week .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>age 18 45 year , inclusive . body mass index ( BMI ) 19 30 kg/m2 , inclusive . healthy determine prestudy medical history , physical examination , vital sign , complete neurological examination 12lead ECG . negative test HBsAg , antiHCVAb HIV1 HIV2 Ab screen clinical laboratory test result clinically acceptable screen admission first treatment period . negative screen alcohol drug abuse screen admission first treatment period . nonsmoker smoke â‰¤ 10 cigarette equivalent per day . able willing give write informed consent . clinically relevant history presence respiratory , gastrointestinal , renal , hepatic , haematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , endocrine , connective tissue diseases disorder . clinically relevant surgical history . clinically relevant family history . history relevant atopy drug hypersensitivity . history alcoholism drug abuse . consume 14 unit alcohol week . significant infection know inflammatory process screen admission first treatment period . acute gastrointestinal symptom ( e.g. , nausea , vomit , diarrhoea , heartburn ) time screen admission first treatment period . use medicine within 2 week admission first period affect safety study assessment , investigator 's opinion . use investigational drug participate clinical trial within 3 month prior screen . participate 2 clinical trial within 12 month prior screen . donate receive blood blood product within 3 month prior screen . vegetarian , vegan medical dietary restriction . could communicate reliably investigator . unlikely cooperate requirement study . unwilling unable give write informed consent .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>